Differences in the immunological responses in drug- and virus-induced cutaneous reactions in children

Blood Cells, Molecules, and Diseases

Volumn 30, Issue 1, 2003, Pages 124-131

  Torres, M J ^a   Corzo, J L ^a   Leyva, L ^a   Mayorga, C ^a   Garcia Martin, F J ^a   Antunez, C ^a   Posadas, S ^b   Jurado, A ^a   Blanca, M ^a,b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cytokines; Drug hypersensitivity; Lymphocyte subpopulations; Skin; Virus

Indexed keywords

ALPHA INTERFERON; CARBAMAZEPINE; CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CEFUROXIME; GAMMA INTERFERON; HOMING RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; LAMOTRIGINE; LYMPHOCYTE SURFACE MARKER; MESSENGER RNA; PHENYTOIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; ERYTHEMA MULTIFORME; FEMALE; FLOW CYTOMETRY; HERPES VIRUS; HUMAN; IMMUNE RESPONSE; MALE; MEMORY CELL; PARVOVIRUS; PATCH TEST; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RASH; SEROCONVERSION; SERODIAGNOSIS; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TOXIC EPIDERMAL NECROLYSIS; VIRUS INFECTION;

EID: 0344089222     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00004-4     Document Type: Article

References (39)

1. Roujeau J.C., Kelly J.P. Severe adverse cutaneous reactions to drugs. N. Engl. J. Med. 331:1994;1272-1285.
2. De Weck A.L. Drugs as allergens. J. Allergy Clin. Immunol. 78:1986;1047-1050.
3. Terrados S., Blanca M., Garcia J., Vega J.M., Torres M.J., Carmona M.J., et al. Non-immediate reactions to betalactams prevalence and role of the different penicillins . Allergy. 50:1995;563-567.
4. Romano A., Quarantino D., Di Fonso M., Papa G., Venuti A., Gasbarrini G. A diagnostic protocol for evaluating non-immediate reactions to aminopenicillins. J. Allergy Clin. Immunol. 103:1999;1186-1190.
5. Hari Y., Urwyler A., Hurni M., Yawalkar N., Dahindan C., Wendland T., et al. Distinct serum cytokine levels in drug and measles induced exanthema. Int. Arch. Allergy Immunol. 120:1998;225-229.
6. Klein J., Horejsi V. Defence against invaders. Klein J., Horejsi V. Immunology. 2nd ed: 1997;532-595 Blackwell Sci, Oxford.
7. Dewdeney J.M. Immunology of the antibiotics. Sela M. The antigens. Vol 5:1997;73-245 Academic Press, New York.
8. Wedderburn L.R., Patel A., Varsani H., Woo P. The developing human immune system T cell receptor repertoire of children and young adults shows a wide discrepancy in the frequency of persistent oligoclonal T cell expansions . Immunology. 102:2001;301-309.
9. Blanca M. Allergic reactions to penicillins. A changing world? Allergy. 502:1995;777-782.
10. Koponen M., Werner J.P., Pichler M.D., De Weck A. T cell reactivity to penicillin phenotypic analysis of in vitro activated cell subsets . J. Allergy Clin. Immunol. 78:1986;645-652.
11. Mauri-Hellweg D., Bettens F., Mauri D., Brander C., Hunziker T., Pichler W.J. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J. Immunol. 155:1995;462-472.
12. Luque I., Leyva L., Torres M.J., Rosal M., Mayorga C., Segura J.M., et al. In vitro T lymphocyte responses to betalactam drugs in immediate and nonimmediate allergic reactions. Allergy. 56:2001;611-618.
13. Padovan E., Bauer T., Tongio M.M., Kalbacher H., Weltzien H.U. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur. J. Immunol. 27:1997;1303-1307.
14. Blanca M., Torres M.J., Leyva L., Mayorga C., Posadas S., Gonzalez L., et al. Expression of the skin-homing receptor in peripheral blood lymphocytes from subjects with nonimmediate cutaneous allergic drug reactions. Allergy. 11:2000;998-1004.
15. Leyva L., Torres M.J., Posadas S., Blanca M., Besso G., Santamaria L.F., et al. Anticonvulsivant-induced toxic epidermal necrolysis monitoring the immunologic response . J. Allergy Clin. Immunol. 105:2000;157-166.
16. Posadas S., Leyva L., Torres M.J., Rodriguez J.L., Bravo I., Rosal M., et al. Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J. Allergy Clin. Immunol. 106:2000;769-776.
17. Romano A. Delayed hypersensitivity to aminopenicillins. Clin. Exp. Allergy. 28:1998;29-32.
18. R. Elias P.M., Fritsch P.O. Erythema and toxic epidermal necrolysis. Fitzpatric T.B., Eisen A.Z., Wolf K., Freedberg I.M., Austen K.I. Dermatology in general practice. 3rd ed :1987;555-567 McGraw-Hill, New York.
19. Leaute-Labreze C., Lamireau T., Chawki D., Maleville J., Taïeb A. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch. Dis. Child. 83:2000;347-352.
20. Chomczysnky P., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
21. Siebert P.D., Larnick J.W. Competitive PCR. Nature. 359:1992;557-558.
22. Amos H.E. The problem of adverse drug reactions. Amos H.E. Allergic drug reactions. 1976;1-5 Arnold, London.
23. Blanca M., Vega J.M., Garcia J., Carmona M.J., Terrados S., Miranda A., et al. Allergy to amoxicillin with good tolerance to other penicillins. Study of the incidence in patients allergic to betalactams. Clin. Exp. Allergy. 20:1990;475-481.
24. Torres M.J., Romano A., Mayorga C., Moya M.C., Guzman A.E., Reche M., et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins the role of skin testing . Allergy. 56:2001;850-856.
25. Blanca M., Mayorga C., Torres M.J., Reche M., Moya M.C., Rodriguez J.L., et al. Clinical evaluation of Pharmacia CAP System™ RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy. Allergy. 56:2001;862-870.
26. Adkinson N.F. Drug allergy. Middleton E. Jr., Reed C.E., Ellis E.F. Allergy principles and practices . 5th ed :1998;1212-1224 Mosby, St. Louis.
27. Arrowsmith J.B., Anello C. A view from a regulatory agency. Storm B.L. Pharmacoepidemiology. 1st ed :1989;69-84 Churchill Livingston, New York.
28. Descamp V., Valance A., Edlinger C., Fillet A.M., Grossin M., Lebrun-Vignes B., et al. Association of human herpes virus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch. Dermatol. 137:2001;301-304.
29. Tohyama M., Yahata Y., Yasukawa M., Inagi R., Urano Y., Yamanishi K., et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch. Dermatol. 134:1998;1113-1117.
30. Bocquet H., Bagot M., Roujeau J.C. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms-DRESS). Semin. Cutan. Med. Surg. 15:1996;250-257.
31. Lunel F., Abuaf N., Frangeul L., Grippon P., Perrin M., Le Coz Y., Valla D., et al. Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology. 16:1992;630-636.
32. Gonzalez F.J., Leyva L., Posadas S., Luque I., Blanca M., Santamaria L., et al. Participation of T lymphocytes in cutaneous allergic reactions to drugs. Clin. Exp. Allergy. 28:1998;3-6.
33. Hert M., Merck H.F. Lymphocyte activation in cutaneous drug reactions. J. Invest. Dermatol. 105:1995;95-98.
34. Maria V.A.J., Victorino R.M.M. Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury. Gut. 41:1997;573-574.
35. Zanni M.P., von Greyerz S., Schnyder B., Mauri-Hellweg D., Brander C., Kalbermatten C., Pichler W.J. T cell reactions in patients showing adverse immune reactions to drugs. Inflamm. Res. 45:1996;79-84.
36. Brugnolo F., Annunziato F., Sampognaro S., Campi P., Manfredi M., Matucci A., et al. Highly Th2-skewed cytokine profile of beta-lactam-specific T cells from nonatopic subjects with adverse drug reactions. J. Immunol. 163:1999;1053-1059.
37. Gonzalez F.J., Carvajal M.J., Leyva L., Juarez C., Blanca M., Santamaria L.F. Expression of the cutaneous lymphocyte-associated antigen in circulating T cells in drug-allergic reactions. Int. Arch. Allergy Immunol. 113:1997;345-347.
38. S.J. Posadas, A. Padial, M.J. Torres, C. Mayorga, L. Leyva, E. Sánchez, et al. Delayed reactions to drugs show levels of perforin, granzyme B and Fas-L related to disease severity. J. Allergy Clin. Immunol. 109 (2002), 155-161.
39. Pichler W.J., Zanni M., Von Greyerz S., Schnyder B., Mauri Hellweg D., Wendland T. High IL-5 production by human drug specific T cell clones. Int. Arch. Allergy Immunol. 113:1997;177-180.